Abstract
A 57-year-old Japanese man was admitted to the hospital with back pain and fever, multiple lung nodules, and abdominal aortic aneurysm (AAA). Laboratory tests performed at admission showed an increased proteinase 3 anti-neutrophil cytoplasmic antibody (PR3-ANCA) level. Video-associated thoracoscopic lung biopsy was performed; pathologic examination showed granulation tissue with necrosis and multinucleated giant cells. The diagnosis of granulomatosis with polyangiitis (GPA) was confirmed on the basis of the clinical presentation, laboratory findings, and lung biopsy. All symptoms were ameliorated, and the serum level of PR3-ANCA declined following treatment with prednisolone and cyclophosphamide. Although the association of GPA with AAA is rare, GPA may be included among the large vessel vasculitides that can give rise to aortic aneurysm.
1. Introduction
Granulomatosis with polyangiitis (GPA) is characterized by a systemic necrotizing vasculitis of medium-sized and small blood vessels [1]. Serum PR3-ANCA has a high sensitivity and specificity for the diagnosis of active GPA (>90%). GPA is characterized by granulomatous upper airway involvement in approximately 90% of patients and renal involvement with necrotizing and crescentic glomerulonephritis in 75% of patients [2]. Chronic inflammation can lead to arterial aneurysm formation, a characteristic of medium-sized vessel vasculitis but a very unusual feature of GPA. Large vessel and medium vessel aneurysms have rarely been described [1]. It is important to recognize aortic or other large vessel involvement owing to the high risk of rupture, dissection, and death.
Here, we report a patient with GPA diagnosed by video-associated thoracoscopic lung biopsies of bilateral lung nodules complicated by an aortic aneurysm and positive anti-PR3-ANCA. The patient underwent successful treatment with prednisolone and cyclophosphamide. The findings were compared with several published reports of large and medium vessel aneurysms in GPA.
2. Case Presentation
A 57-year-old Japanese man was admitted to our hospital with a chief complaint of back pain and fever for one month. A computed tomography (CT) scan showed an aneurysm of the infrarenal aorta, with a diameter of 34 mm, and inflammation of the surrounding adipose tissue, nodular lesions of the bilateral lungs, and left maxillary sinusitis (Figure 1). He was referred to our hospital for further evaluation and treatment.
At the time of admission, the patient was 168 cm tall and weighed 56.6 kg. His blood pressure was 98/69 mmHg, pulse was 84 beats per minute, and body temperature was 39.6°C. Serum creatinine was 0.66 mg/mL, and urinalysis showed 1+ occult blood; urinary sediment contained 20 red blood cells per high-power field. Serum analysis showed leukocytosis (10,000/μL) and an elevated C-reactive protein level (29.5 mg/dL). The anti-PR3-ANCA level was 187 IU/mL, and the anti-MPO-ANCA level was normal. The abdominal aortic aneurysm was suspected to be infected, and we began administering antibiotics. The patient's general medical condition failed to improve.
The clinical findings of left maxillary sinusitis, multiple nodular lesions in the lungs, fever, and positive anti-PR3-ANCA were clinically suspicious for GPA. Video-associated thoracoscopic lung biopsy was performed. The biopsy specimens demonstrated granulation tissue with necrosis and multinucleated giant cells (Figure 2). Most infiltrating cells were neutrophils. The ratio (%) of IgG4 to total IgG-positive cells was 33%, and there were 60 IgG4+ plasma cells per HPF in the lung.
The patient was diagnosed with GPA. He was treated with an intravenous semipulse dose of methylprednisolone, followed by oral prednisolone 1 mg/kg (55 mg) per day and intravenous administration of cyclophosphamide (700 mg/body once per month). All of the patient's symptoms and CT findings rapidly improved (Figure 1(d)), and the PR3-ANCA level promptly decreased to the normal range. The diameter of the aneurysm changed from 34 mm to 21 mm after treatment. On tapering doses of steroids, the patient is currently in remission, and the inflammation and PR3-ANCA elevation have completely resolved. There has been no disease recurrence for 4 years after initiation of therapy.
3. Discussion
GPA is one of the ANCA-associated small vasculitides [3]. GPA is characterized by systemic necrotizing inflammation of small- to medium-sized blood vessels and granulomatous upper airway involvement in approximately 90% of patients; renal involvement with necrotizing and crescentic glomerulonephritis occurs in 75% of patients. Other organs including the skin, joints, heart, central nervous system, and eyes can also be affected [2].
Our patient developed lung nodules and abdominal aneurysm with inflammation, an unusual manifestation of GPA. Normally, aortic lesions are more frequently seen in large vessel vasculitis, such as giant cell arteritis and Takayasu's arteritis [4]. In our case, abdominal aneurysms showed findings of chronic periaortitis (CP) which were characterized by deposition of fibroinflammatory, periaortic tissue with the retroperitoneal tissue. The aortic diameter of CP is often normal at the time of diagnosis [5]. The differential diagnosis of CP includes abdominal aortic aneurysm, syphilitic mesoarteritis [6], IgG4-related disease (IgG4-RD) [7], Takayasu's arteritis [8], temporal arteritis [9], and infectious arteritis [10]. Takayasu's and temporal arteritis may lead to vascular occlusion and tissue ischemia. Syphilitic mesoarteritis and infectious arteritis were ruled out by serological findings and negative cultures, respectively. Takayasu's arteritis and temporal arteritis were also ruled out by the absence of vascular occlusion and tissue ischemia. We considered the possibility of a case of overlapping GPA and IgG4-RD. It was unclear whether the CP was due to vasculitis, granulomatous inflammation, or a predominant IgG4-RD-like pathology because histological samples of the aorta were not available. Danlos et al. proposed an overlap of IgG4-RD/ANCA-associated vasculitides (AVV) [11]. In their study, nearly half the patients met only one of the two immunohistological criteria of IgG4-RD (IgG4+/IgG+ plasma cell ratio > 40% and >10IgG4+ plasma cell per HPF) although tissue samples were obtained from the lesion with a typical IgG4-RD organ, and histologic patterns did not overlap in the same tissue [12]. Therefore, some patients that they considered to have overlap syndrome of IgG4-RD and AVV had no histological confirmation of IgG4-RD but did have suggestive manifestations and elevated serum IgG4 levels. Our patient had slightly elevated serum IgG4 (131 mg/dL) and CP. The ratio of IgG4-positive plasma cells to IgG-positive plasma cells (33%) did not meet the criteria for IgG4-RD, but the amount of IgG4-positive plasma cells per high-power field was very high. Thus, our patient was most likely to have overlap of IgG4-RD and GPA.
Arterial aneurysm is a very rare complication of GPA. A review of the literature identified 20 cases with arterial aneurysms in GPA, including aortic involvement in 10 patients (Table 1) [1, 13–30]. Of the 20 total reported cases, in 9 patients the aneurysm ruptured, leading to death from hemorrhage in 5 patients. All of these patients were treated with medications such as steroids and cyclophosphamide, but medical treatment could not prevent aortic rupture, and the patients ultimately died. In the remaining 11 patients, including 7 with aneurysms of the aorta that did not rupture, disease remission was achieved with surgery in 6 patients and medication with prednisolone and cyclophosphamide in 1 patient. Rupture was prevented in all 10 patients who were treated surgically.
Table 1.
Case | Age/gender (years) | Affected site | Antibodies | Duration of complaint | Treatment | Rupture | Outcome |
---|---|---|---|---|---|---|---|
1 [1] | 38/M | TAA | Anti-neutrophil cytoplasmic antibodies × 128 | NS | Surgery (J-graft) + PSL 15 mg/day | Yes | Good |
2 [13] | 51/M | Distal part of aorta (3.8 cm) | Anti-proteinase-3 antibodies > 530 kU/L | 2 months | Steroid pulse + PSL 1 mg/kg + CY 2 mg/kg/day | No | Good |
3 [14] | 45/M | Aorta, extending to the right iliac artery | ANCA + NS | 5 days | Right ureterolysis + immunosuppressive therapy | No | Good |
4 [15] | 33/M | AAA | Antiproteinase-3 (>1/10) | 3 weeks | IJV graft + PSL + CY | No | Good |
5 [16] | 42/M | AAA | Antiproteinase-3 157 AU/l | 1 month | Aortoiliac graft and high-dose PSL + CY 2 mg/kg/day | No | Good |
6 [17] | 63/M | AAA (5.4 cm) | p-ANCA 1/80 and MPO 28 U/l | 2 months | Surgery + PSL 1 mg/kg + CY 2 mg/kg | No | Good |
7 [18] | 50/F | TAA | p-ANCA (1 : 320) antimyeloperoxidase 440 U/ml | 2 months | PSL + CY | Yes | Death |
8 [19] | 43/M | Infrarenal aorta (3.1 × 3.5 cm) | NS | 1 week | PSL + surgery | No | Good |
9 [20] | 29/M | Branches of hepatic and renal arteries | Anti-PR3 ANCA 15 IU/mL | NS | Coil embolization + steroid pulse + PSL 60 mg + MMF 2.5 g | No | Good |
10 [21] | 34/M | Anterior choroidal artery | PR3 ANCA 457 EU | 1 year | Clipping + steroid pulse + PSL 40 mg + CY | Yes | Good |
11 [22] | 67/M | Superior pancreaticoduodenal artery | C-ANCA 1 : 512 PR3 ANCA 88 IU/L | 11 months | IVCY (0.7 g/m2) every 3 weeks + steroid pulse + PSL 1 mg/kg/day | Yes | Death |
12 [23] | 58/F | Subclavian aneurysm | P-ANCA 68 units | 2 months | PSL 1 mg/kg + CY 2 mg/kg + stent graft | No | Good |
13 [24] | 56/M | Left gastric artery | C-ANCA positive | 1 month | None | Yes | Death |
14 [25] | 55/M | Hepatic artery | C-ANCA 1 : 80 | 3 weeks | mPSL + CY | Yes | Death |
15 [26] | 24/M | Bilateral renal artery | NS | 6 weeks | PSL 30 mg + CY 150 mg/day | Yes | Good |
16 [27] | 59/M | Aorta | C-ANCA 158 SLI units | 9 months | Coronary artery bypass + steroid pulse + PSL + CY 3 mg/kg + plasmapheresis | No | Good |
17 [28] | 35/M | Hepatic, renal, splanchnic | C-ANCA positive | 6 weeks | Steroid pulse + PSL + IVCY 750 mg | Yes | Good |
18 [29] | 30/M | Renal artery | NS | 1 month | PSL 1 mg/kg/day and CY 2 mg/kg/day | No | Good |
19 [30] | 53/F | Renal artery | NS | 20 days | PSL 1 mg/kg/day + CY 2 mg/kg/day + hemodialysis | No | Good |
20 [30] | 79/M | TAA | PR3-ANCA 1180 EU | 8 months | Steroid pulse PSL 60 mg + IVCY 300 mg | Yes | Death |
Present case | 58/M | AAA | PR3 ANCA 187 IU/ml | 2 weeks | Steroid pulse + PSL 55 mg + IVCY 500 mg | No | Good |
TAA: thoracic aortic aneurysm; AAA: abdominal aortic aneurysm; F: female; M: male; NS: not stated; PSL: prednisolone; CY: cyclophosphamide; mPSL: methylprednisolone; MMF: mycophenolate mofetil; IVCY: intravenous cyclophosphamide; IJV: internal jugular vein.
Patients with aortic aneurysm can be managed via medical or surgical approaches. Similarly, arterial aneurysms in patients with GPA can be managed by both approaches. Corticosteroids and cyclophosphamide are reportedly effective for the treatment of GPA with arterial aneurysms. Surgery is generally recommended when the diameter of an abdominal aortic aneurysm is >60 mm. Endovascular aneurysm repair (EAR) is recommended when inflammatory aortic aneurysm (IAA) causes the thickness of retroperitoneum or adhesion of urinary duct. Medication is recommended in the case of infectious aneurysm [31]. We decided to administer corticosteroids and cyclophosphamide because the diameter of the aneurysm in our patient was 34 mm; we chose not to perform select EAR because we could not rule out the possibility of infectious aneurysm. IAA is often treated with EAR, which can reduce the risk associated with severe intraoperative cardiac and pulmonary complications [32]. Immunosuppressive therapies could reduce adventitial thickening; however, we needed to consider the risk of aneurysmal rupture due to thinning of the adventitia. The condition of the aneurysm should be checked by imaging frequently because it cannot be predicted when the aneurysm might rupture after treatment.
In conclusion, we present a rare case of GPA with lung nodules and abdominal aortic aneurysm. GPA should be included in the differential diagnosis of large vessel vasculitis, which can give rise life-threatening periaortic inflammation. The possibility of aneurysmal rupture should be carefully considered when administering immunosuppressive therapies for GPA with aneurysm.
Consent
A written informed consent for publication of this case report and for genetic analysis of the patient has been obtained from the patient.
Conflicts of Interest
The authors declare that they have no conflicts of interest.
References
- 1.Ohta N., Waki T., Fukase S., et al. Aortic aneurysm rupture as a rare complication of granulomatosis with polyangiitis: a case report. Journal of Medical Case Reports. 2013;7(1):p. 202. doi: 10.1186/1752-1947-7-202. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Hoffman G. S., Kerr G. S., Leavitt R. Y., et al. Wegener granulomatosis: an analysis of 158 patients. Annals of Internal Medicine. 1992;116(6):488–498. doi: 10.7326/0003-4819-116-6-488. [DOI] [PubMed] [Google Scholar]
- 3.Seo P., Stone J. H. The antineutrophil cytoplasmic antibody-associated vasculitides. American Journal of Medicine. 2004;117(1):39–50. doi: 10.1016/j.amjmed.2004.02.030. [DOI] [PubMed] [Google Scholar]
- 4.Mukhtyar C. B., Flossmann O., Luqmani R. A. Clinical and biological assessment in systemic necrotizing vasculitides. Clinical and Experimental Rheumatology. 2006;24:S92–S99. [PubMed] [Google Scholar]
- 5.Caspary L. Inflammatory diseases of the aorta. Vasa. 2016;45(1):17–29. doi: 10.1024/0301-1526/a000491. [DOI] [PubMed] [Google Scholar]
- 6.Sato K., Chiba K., Koizumi N., Ogino H. Successful repair of a syphilitic aortic arch aneurysm accompanied by serious cerebral infarction. Annals of Thoracic and Cardiovascular Surgery. 2014;20:929–932. doi: 10.5761/atcs.cr.13-00149. [DOI] [PubMed] [Google Scholar]
- 7.Kasashima S., Zen Y. IgG4-related inflammatory abdominal aortic aneurysm. Current Opinion in Rheumatology. 2011;23(1):18–23. doi: 10.1097/bor.0b013e32833ee95f. [DOI] [PubMed] [Google Scholar]
- 8.Arend W. P., Michel B. A., Bloch D. A., et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis and Rheumatism. 1990;33(8):1129–1134. doi: 10.1002/art.1780330811. [DOI] [PubMed] [Google Scholar]
- 9.Gornik H. L., Creager M. A. Aortitis. Circulation. 2008;117(23):3039–3051. doi: 10.1161/circulationaha.107.760686. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Valentine R. J., Chung J. Primary vascular infection. Current Problems in Surgery. 2012;49(3):128–182. doi: 10.1067/j.cpsurg.2011.11.004. [DOI] [PubMed] [Google Scholar]
- 11.Umehara H., Okazaki K., Masaki Y., et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Modern Rheumatology. 2012;22:21–30. doi: 10.1007/s10165-011-0571-z. [DOI] [PubMed] [Google Scholar]
- 12.Danlos F. X., Rossi G. M., Blockmans D., et al. Antineutrophil cytoplasmic antibody-associated vasculitides and IgG4-related disease: a new overlap syndrome. Autoimmunity Reviews. 2017;16(10):1036–1043. doi: 10.1016/j.autrev.2017.07.020. [DOI] [PubMed] [Google Scholar]
- 13.Minnee R. C., van den Berk G. E., Groeneveld J. O., et al. Aortic aneurysm and orchitis due to Wegener’s granulomatosis. Annals of Vascular Surgery. 2009;23(6):p. 786. doi: 10.1016/j.avsg.2009.06.011. [DOI] [PubMed] [Google Scholar]
- 14.Fink A. M., Miles K. A., Wraight E. P. Indium-111 labelled leucocyte uptake in aortitis. Clinical Radiology. 1994;49(12):863–866. doi: 10.1016/s0009-9260(05)82876-4. [DOI] [PubMed] [Google Scholar]
- 15.Durai R., Agrawal R., Piper K., Brohi K. Wegener’s granulomatosis presenting as an abdominal aortic aneurysm: a case report. Cases Journal. 2009;2(1):p. 9346. doi: 10.1186/1757-1626-2-9346. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Blockmans D., Baeyens H., Van Loon R., Lauwers G., Bobbaers H. Periaortitis and aortic dissection due to Wegener’s granulomatosis. Clinical Rheumatology. 2000;19(2):161–164. doi: 10.1007/s100670050038. [DOI] [PubMed] [Google Scholar]
- 17.Carels T., Verbeken E., Blockmans D. p-ANCA-associated periaortitis with histological proof of Wegener’s granulomatosis: case report. Clinical Rheumatology. 2005;24:83–86. doi: 10.1007/s10067-004-0998-0. [DOI] [PubMed] [Google Scholar]
- 18.Chirinos J. A., Tamariz L. J., Lopes G., et al. Large vessel involvement in ANCA-associated vasculitides: report of a case and review of the literature. Clinical Rheumatology. 2004;23(2):152–159. doi: 10.1007/s10067-003-0816-0. [DOI] [PubMed] [Google Scholar]
- 19.Unlu C., Willems M., Ten Berge I. J., Legemate D. A. Aortitis with aneurysm formation as a rare complication of Wegener’s granulomatosis. Journal of Vascular Surgery. 2011;54(5):1485–1487. doi: 10.1016/j.jvs.2011.05.014. [DOI] [PubMed] [Google Scholar]
- 20.Arlet J. B., Le Thi Huong D., Marinho A., Cluzel P., Wechsler B., Piette J. C. Arterial aneurysms in Wegener’s granulomatosis: case report and literature review. Seminars in Arthritis and Rheumatism. 2008;37(4):265–268. doi: 10.1016/j.semarthrit.2007.07.004. [DOI] [PubMed] [Google Scholar]
- 21.Takei H., Komaba Y., Kitamura H., et al. Aneurysmal subarachnoid hemorrhage in a patient with Wegener’s granulomatosis. Journal of Clinical and Experimental Nephrology. 2004;8(3):274–278. doi: 10.1007/s10157-004-0280-4. [DOI] [PubMed] [Google Scholar]
- 22.Famularo G., De Cata A., Bracci M., Minisola G., De Simone C., Nicotra G. C. Fatal rupture of an inflammatory arterial aneurysm in a patient with Wegener’s granulomatosis. Scandinavian Journal of Rheumatology. 2004;33(4):277–279. doi: 10.1080/03009740410005908. [DOI] [PubMed] [Google Scholar]
- 23.Shitrit D., Shitrit A. B., Starobin D., et al. Large vessel aneurysms in Wegener’s granulomatosis. Journal of Vascular Surgery. 2002;36(4):856–858. doi: 10.1067/mva.2002.126088. [DOI] [PubMed] [Google Scholar]
- 24.Aoki N., Soma K., Owada T., Ishii H. Wegener’s granulomatosis complicated by arterial aneurysm. Internal Medicine. 1995;34(8):790–793. doi: 10.2169/internalmedicine.34.790. [DOI] [PubMed] [Google Scholar]
- 25.den Bakker M. A., Tangkau P. L., Steffens T. W., Tjiam S. L., van der Loo E. M. Rupture of a hepatic artery aneurysm caused by Wegener’s granulomatosis. Pathology–Research and Practice. 1997;193(1):61–66. doi: 10.1016/s0344-0338(97)80096-9. [DOI] [PubMed] [Google Scholar]
- 26.Baker S. B., Robinson D. R. Unusual renal manifestations of Wegener’s granulomatosis. Report of two cases. American Journal of Medicine. 1978;64(5):883–889. doi: 10.1016/0002-9343(78)90532-6. [DOI] [PubMed] [Google Scholar]
- 27.Sieber S. C., Cuello B., Gelfman N. A., Garfinkel H. B. Pulmonary capillaritis and glomerulonephritis in an antineutrophil cytoplasmic antibody-positive patient with prior granulomatous aortitis. Archives of Pathology and Laboratory Medicine. 1990;114:1223–1226. [PubMed] [Google Scholar]
- 28.Senf R., Jurgensen J. S., Teichgraber U., Kampf D., Schindler R. Ruptured arterial aneurysm of the kidney in a patient with Wegener’s granulomatosis. Nephrology Dialysis Transplantation. 2003;18(12):2671–2673. doi: 10.1093/ndt/gfg380. [DOI] [PubMed] [Google Scholar]
- 29.Moutsopoulos H. M., Avgerinos P. C., Tsampoulas C. G., Katsiotis P. A. Selective renal angiography in Wegener’s granulomatosis. Annals of the Rheumatic Diseases. 1983;42(2):192–195. doi: 10.1136/ard.42.2.192. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Toda M., Masuda H., Tanaka A., et al. A case aneurysm on the descending thoracic aorta in Wegener’s granulomatosis. Dokkyo Journal of Medical Sciences. 2011;38:119–126. in Japanese. [Google Scholar]
- 31.JCS Joint Working Group. Guidelines for diagnosis and treatment of aortic aneurysm and aortic dissection (JCS 2011): digest version. Circulation Journal. 2013;77(3):789–828. doi: 10.1253/circj.cj-66-0057. [DOI] [PubMed] [Google Scholar]
- 32.Puchner S., Bucek R. A., Rand T., et al. Endovascular therapy of inflammatory aortic aneurysms: a meta-analysis. Journal of Endovascular Therapy. 2005;12(5):560–567. doi: 10.1583/05-1571.1. [DOI] [PubMed] [Google Scholar]